OPIOID PRESCRIBING RULES. May 17, 2017 Webinar

Similar documents
Rule Governing the Prescribing of Opioids for Pain

OHSU. Vermont s Response to the Opioid Crisis Alumni Scientific Session Dr. Harry Chen Commissioner of Health (former)

Prescription Opioids in Vermont A DISCUSSION ABOUT LAWS AND GUIDELINES MICHAEL J. KENOSH, MD

Literature year in review: Fast take

Opioid Management of Chronic (Non- Cancer) Pain

Prescription Monitoring Program (PMP)

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

UVM ECHO Chronic Pain: Management of Opioid Prescribing in Primary Care

Vermont. Prescribing and Dispensing Profile. Research current through November 2015.

Impact of Opioid Prescribing Rules in Post Acute and Long Term Care

Oklahoma. Prescribing and Dispensing Profile. Research current through November 2015.

Pain: Assessment, Non-Opioid Treatment Approaches and Opioid Management

The Opioid Crisis: Effectiveness of State Responses

Best Practices in Prescribing Opioids for Chronic Non-cancer Pain

Prescription Opioid Overdose in Oregon: A public health perspective

Appropriate Opioid Prescribing for Acute Pain after Surgery

Tennessee. Prescribing and Dispensing Profile. Research current through November 2015.

Opioid Review and MAT Clinic CDC Guidelines

PRESCRIBING GUIDELINES

The Opioid Epidemic: What is the Role of Acute Pain Prescribing?

CDC Guideline for Prescribing Opioids for Chronic Pain

Opioid Prescribing Improvement Program

Welcome - we will begin the webinar shortly Please read the participation tips below:

Oregon Opioid Overdose Prevention Initiative

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Readopt with amendment Med 502, effective (Document #11090), to read as follows:

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

New Guidelines for Opioid Prescribing

Bree Collaborative AMDG Opioid Prescribing Guidelines Workgroup. Opioid Prescribing Metrics - DRAFT

HOPE. Considerations. Considerations ISING. Safe Opioid Prescribing Guidelines for ACUTE Non-Malignant Pain

Opioid Analgesics. Recommended starting dose for opioid-naïve patients

Appropriate Opioid Prescribing for Acute Pain after Surgery

New Medicare Part D Prescription Opioid Policies for 2019 Information for Prescribers

WHY GOOD PAIN MANAGEMENT IS GOOD DRUG ABUSE PREVENTION

PACIFICSOURCE COMMUNITY SOLUTIONS AND GORGE COORDINATED CARE ORGANIZATION. Chronic Pain and Opiate Management Initiatives

Update on Maine Laws and Associated Rules on Prescribing Opioid Medication

Opioid epidemic and PEHP

Questions and answers about HCA s opioid clinical policy for Apple Health (Medicaid)

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Section I. Short-acting opioid Prior Authorization Criteria

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES

OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

2016 Dr. Douglas H. Kay CPE Symposium

Cynthia B. Jones, Director Department of Medical Assistance Services (DMAS)

Update on Maine Laws and Associated Rules on Prescribing Opioid Medication

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Reversing America s Opioid Epidemic. August 2017

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

Vermont Hub and Spoke Model Treatment Need Questionnaire

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

The Role of Dentists in Preventing Opioid Abuse Tufts Health Care Institute Program on Opioid Risk Management 12 th Summit Meeting March 11-12, 2010

The Morbidity and Mortality of Kansas Drug Epidemic

On December 27, 2017, the Lieutenant Governor signed into law several new requirements

California. Prescribing and Dispensing Profile. Research current through November 2015.

Managing Pain in Individuals with Serious Illness and Comorbid Substance Use Disorder

Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable

Scope of the Opiate Problem 6/5/18. Chronic Pain Management and the Use of Opioid Medications: The CDC Guideline and Beyond. Overview.

Status of Opioid Treatment Efforts

Prior Authorization for Opioid Products Indicated for Pain Management

Medication Assisted Treatment. Nicole Gastala, MD

Virginia. Prescribing and Dispensing Profile. Research current through November 2015.

A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH

Managed Care Pushes for Safer Opioid Oversight

Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017

Barriers to recovery for Buprenorphine Patients in Bangor, Maine

NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)

Standard of Practice for Prescribing Opioids (Excluding Cancer, Palliative, and End-of-Life Care)

State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP

The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health

Proposed Revision to Med (i)

MARYLAND BOARD OF PHARMACY

The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH 6/30/2017

Policy and Issuance Patient Age Group: ( ) N/A ( ) All Ages ( ) Newborns ( X) Pediatric ( X) Adult

Revised 9/30/2016. Primary Care Provider Pain Management Toolkit

Maine s New Opioid Prescribing Law & the Opioid Crisis: Implications for Providers

Opioid Prescribing Tips & Tricks CANDY STOCKTON, MD MAY 2018

Blue Cross of Idaho Addresses State s Opioid Issue

PAIN MANAGEMENT DISCHARGE COMMUNICATION (PM-DC) AUDIT TOOL

Safe Prescribing of Drugs with Potential for Misuse/Diversion

D. Janene Holladay, M.D. Board Certifications: American Board of Anesthesiology American Board of Pain Medicine American Board of Addiction Medicine

OPIOID REDUCTION INITIATIVE FOR SURGICAL PATIENTS AT KAISER PERMANENTE

MQAC Rules for the Management of Chronic Non-Cancer Pain For Allopathic Physicians Effective January 2, 2012

The Opioid Epidemic and How It is Impacting the Workplace. July 24, 2018

Evaluation of the N.C. Prescription

The Role of Acute Care Prescribing in the Opioid Epidemic

Subject: Pain Management (Page 1 of 7)

Opioid Report Card. opioid oversight from MN Dept of Health

Pennsylvania Prescription Drug Monitoring Program Trends,

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

Now available. A maintenance dose of SUBOXONE mg once daily is clinically effective for most patients*1. Once-daily dosing in a single tablet

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Evidence-Based Postoperative Opioid Prescribing Guidelines

Department of Veterans Affairs Network Policy No.: VA Desert Pacific Healthcare Network (VISN 22) Date: September 23, 2014 Long Beach, CA

Dangerous Liaisons. Overdose, Diversion & Deception

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Transcription:

OPIOID PRESCRIBING RULES May 17, 2017 Webinar

Outline Introduction and Universal Precautions Dr. Levine, Commissioner, Health Department 15 Minutes Acute Pain Dr. Patti Fisher, UVMMC 20 Minutes Chronic Pain Dr. Carlos Pino, UVMMC 10 minutes VPMS Hannah Hauser, VPMS Program Manager 10 Minutes Questions 15 Minutes Vermont Department of Health

The Problem As many as four out of five heroin users begin by abusing prescription drugs Of those who abuse prescription opioids, seven out of 10 received these drugs through methods of diversion Opioids are overprescribed. They are prescribed: Too often At too high a dose For too long Prescribers play a role in the supply and use of opioids in our and use of opioids in communities. Vermont Department of Health

Patient-level surveys of opioid use after surgery Dartmouth Hitchcock researchers examined opioid prescribing patterns after general surgery outpatient procedures. Results: Wide variation in quantity provided for each operation An average of only 28% of pills were used To satisfy 80% of patient needs, could reduce prescription amounts by 43% 1: Hill M, McMahon M, Stucke R, & Barth R. Wide Variation and Excessive Dosage of Opioid Prescriptions for Common General Surgical Procedures. Annals of Surgery. 2016; doi: 10.1097/SLA.0000000000001993

Patient-level surveys of opioid use after surgery UVM study (Nov. 2016), after general and orthopedic surgery, same wide variation found even within a practice. Results: 7% did not receive an opioid Of the 93% who received an opioid 12% did not fill the prescription 30% that filled the prescription didn t use any The overall median proportion used = 26% Vermont Department of Health

New Persistent Opioid Use After Minor and Major Surgical Procedures in US Adults In a cohort of previously opioid-naive patients, approximately 6% continued to use opioids more than 3 months after their surgery, and as such, prolonged opioid use can be deemed the most common postsurgical complication. New persistent opioid use is not different among patients who underwent minor and major surgical procedures, thereby suggesting that prolonged opioid use is not entirely due to surgical pain. Chad M. Brummett, MD1,2; Jennifer F. Waljee, MD, MPH, MS2,3; Jenna Goesling, PhD1; et al JAMA Surg. Published online April 12, 2017. doi:10.1001/jamasurg.2017.0504

High-Level Overview of Rules Note that providers should read the full rules which can be found here: http://www.healthvermont.gov/about-us/lawsregulations/rules-and-regulations

Universal Precautions First consider non-opioid and nonpharmacologic treatments Upon first prescription prescribers must: discuss risks and safe storage and disposal provide a patient education sheet, and receive an informed consent for all first opioid prescriptions Co-prescribe naloxone for prescriptions over 90 MME or if also on benzodiazepines Check the prescription monitoring system for everyone s first prescription exceeding 10 pills or a replacement prescription Vermont Department of Health

Opioid Prescribing for Acute Pain First prescription to opioid naïve patients: Consider non-opioid treatment Prescribe minimum needed for pain 350 MME (50 MME per day for 7 days) limit Ensure a safe transition of care to patients PCP Avoid long-acting opioids Vermont Department of Health

MME Limits for First Prescription for Opioid Naïve Patients Ages 18+ Pain Average Daily MME (allowing for tapering) Prescription TOTAL MME based on expected duration of pain Common average DAILY pill counts Commonly associated injuries, conditions and surgeries Minor pain No Opioids 0 total MME 0 hydrocodone 0 oxycodone 0 hydromorphone molar removal, sprains, non-specific low back pain, headaches, fibromyalgia, un-diagnosed dental pain Moderate pain 24 MME/day 0-3 days: 72 MME 1-5 days: 120 MME 4 hydrocodone 5mg or 3 oxycodone 5mg or 3 hydromorphone 2mg non-compound bone fractures, most soft tissue surgeries, most outpatient laparoscopic surgeries, shoulder arthroscopy Severe pain 32 MME/day 0-3 days: 96 MME 1-5 days: 160 MME Extreme Pain 50 MME/day 7 day MAX: 350 MME 6 hydrocodone 5mg or 4 oxycodone 5mg or 4 hydromorphone 2mg 10 hydrocodone 5mg or 6 oxycodone 5mg or 6 hydromorphone 2mg many non-laparoscopic surgeries, maxillofacial surgery, total joint replacement, compound fracture repair For patients with severe pain and extreme circumstance, the provider can make a clinical judgement to prescribe up to 7 days so long as the reason is documented in the medical record. similar to the severe pain category but with complications or other special circumstances Exemptions: active and aftercare cancer treatment, palliative care, end-of-life and hospice care, patients in skilled and intermediate care nursing facilities, multi-system trauma, complex surgical interventions such as spinal surgery, persons released from an in-patient care setting with uncontrolled pain, patients on medication-assisted treatment for substance use disorder, patients who are not opioid naïve (have had opioids within past 30 days)

Opioid Prescribing for Minors Teens who used opioids for legitimate reasons in high school had a 33% increased risk for future misuse compared to their peers. 1 Consult with pediatrician before prescribing in ED Opioids as last resort for minor injuries Limits the first prescription to a total of 72 MME (24 MME for 3 days) Vermont Department of Health 1 Miech R, Johnston L, O Malley PM, Keyes KM, Heard K. Prescription Opioids in Adolescence and Future Opioid Misuse. Pediatrics. 2015;136(5):e1169-e1177.

MME Limits for First Prescription for Opioid Naïve Patients Ages 0-17 Pain Average Daily MME (allowing for tapering) Prescription TOTAL MME based on expected duration of pain Common average DAILY pill counts Commonly associated injuries, conditions and surgeries Minor pain No Opioids 0 total MME 0 hydrocodone 0 oxycodone 0 hydromorphone molar removal, sprains, non-specific low back pain, headaches, fibromyalgia, un-diagnosed dental pain Moderate to Severe pain 24 MME/day 0-3 days: 72 MME 4 hydrocodone 5mg or 3 oxycodone 5mg or 3 hydromorphone 2mg non-compound bone fractures, most soft tissue surgeries, most outpatient laparoscopic surgeries, shoulder arthroscopy Exemptions: active and aftercare cancer treatment, palliative care, end-of-life and hospice care, patients in skilled and intermediate care nursing facilities, multi-system trauma, complex surgical interventions such as spinal surgery, persons released from an in-patient care setting with uncontrolled pain, patients on medication-assisted treatment for substance use disorder, patients who are not opioid naïve (have had opioids within past 30 days)

Prescribing Opioids for Acute Pain Prescribing limits do not apply to palliative care end of life or hospice care patients in nursing facilities pain associated with significant or severe trauma pain associated with complex surgical interventions such as spinal surgery pain associated with prolonged inpatient care due to surgical complications medication assisted treatment for substance use disorders patients who are not opiate naive 13

Opioid Prescribing for Chronic Pain Screening, Evaluation and Risk Assessment Documented medical evaluation including a physical exam Document any diagnoses which support the use of opioids Document what non-opioid, including non-pharmacologic treatments that have been tried or considered Evaluate and document benefits and the individual patient s relative risks (including risk for misuse, abuse, addiction or overdose for the individual) Perform an assessment of any comorbid conditions affected by the treatment with opioids Screen for the use of other controlled substances including MAT with methadone or buprenorphine

Opioid Prescribing for Chronic Pain Universal precautions apply Informed Consent, Controlled Substance Treatment Agreement to be repeated annually Requires pain management plans and ongoing assessments of opioid effectiveness Sets a trigger for revaluation at 90 MME Stable patients must be evaluated at least every 90 days Co-prescribe naloxone for prescriptions over 90 MME or if also on benzodiazepines Vermont Department of Health

Opioid Prescribing for Chronic Pain Every 90 day re-evaluation Dose Effectiveness Adherence to treatment regimen (not just opioid rx) Functional assessment Potential for the use of non-opioid or non-pharmacologic alternatives Any co-morbid conditions that may be affected by treatment with opioids Assessment of individual risk factors that may lead the prescriber to modify the pain management regimen

Prism requirements for Chronic Pain Patients Chronic Pain in problem list Enroll patient in chronic pain topic in Health Maintenance Informed consent and prescription agreement Tracking UDS, pill counts Functional assessment at clinician-dictated interval Screening for substance use (COMM)

VPMS Rules: Required Prescriber Queries The first time the provider prescribes an opioid Starting long-term pain therapy of 90 days or more Prior to writing a replacement prescription At least annually for patients who are receiving ongoing treatment The first time prescriber prescribes a benzodiazepine When a patient requests an opioid or a renewal from an Emergency Department or Urgent Care Center Vermont Department of Health

Law Requires Dispensers to query the Vermont Prescription Monitoring System Dispensers must check the prescription monitoring system when: Dispensing an opioid to a new patient A patient pays cash for an opioid, but has insurance A patient requests a refill of an opioid before it is due The dispenser knows the patient is being prescribed an opioid by more than one prescriber Exemption for a hospital-based dispenser dispensing a quantity of an opioid that is sufficient to treat a patient for 48 hours or fewer. Vermont Department of Health

If you remember nothing else First consider non-opioid and nonpharmacologic treatments Upon first prescription, prescribers must: discuss risks and safe storage and disposal provide a patient education sheet, and receive an informed consent for all first opioid prescriptions

If you remember nothing else. For acute pain in opioid naïve adult patients: 350 MME (50 MME per day for 7 days) limit Use the table, noting bolded items are maximums For chronic pain: screening, evaluation, risk assessment, universal precautions: Re-evaluation trigger 90 MME Stable patients must be evaluated at least every 90 days Naloxone co-prescription: for prescriptions over 90 MME or concomitant benzodiazepines

If you remember nothing else regarding when to query VPMS First time opioid prescription exceeding 10 pills or replacement prescription For chronic pain: starting nonpalliative long-term prescription over 90 days and annual for ongoing prescription First time benzodiazepine prescription

Resources Act 173 An act relating to combating opioid abuse in Vermont http://legislature.vermont.gov/assets/documents/2016/docs/acts/act173/act173%20as%20enacted.pdf VDH Rule Governing the Prescribing of Opioids for Pain http://www.healthvermont.gov/sites/default/files/documents/2016/12/reg_opioids-prescribing-for-pain.pdf VDH Vermont Prescription Monitoring Rule http://www.healthvermont.gov/sites/default/files/documents/2016/12/reg_vpms-20170701.pdf Patient Information Sheet http://www.healthvermont.gov/alcohol-drugs/professionals/resources-patients-and-providers Informed Consent Template http://www.healthvermont.gov/alcohol-drugs/professionals/resources-patients-and-providers Office of Primary Care and Area Health Education Centers (AHEC) Program http://www.med.uvm.edu/ahec/workforceresearchdevelopment/toolkits-and-workbooks/opioid_prescribing Vermont Department of Health

Contacts Vermont Prescription Monitoring System Hannah Hauser Hannah.Hauser@Vermont.Gov 802-652-4147 Opioid Prescribing Rules David Englander David.Englander@Vermont.Gov 802-863-7280 Quality Improvement Assistance Nicole Rau Nicole.Rau@Vermont.gov 802-951-5803